07.05.24 -- How Generative AI Could Change Pharmaceutical Manufacturing

What does Annex 21 entail? What makes the process of meeting the requirements so complex and time-consuming? And has Annex 21 inadvertently created additional barriers to supply?

Watch to explore the relationship between a contamination control strategy (CCS) and the development of a robust cleaning and disinfection program for cleanroom environments.

Using QRM allows a company to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.

In a laboratory setting, data is everywhere. Learn in-depth about data challenges, the importance of data lifecycle management in laboratories, and the need for data sustainability.

Dive into this overview of the evolving regulatory landscape and better understand the importance of proactive planning, collaboration, and expert guidance in navigating the ATMPs ecosystem in Europe.

Establishing an organization that can manage a diverse development pipeline for oncology therapies requires an equally diverse wealth of expertise.

Explore how many organizations have not fully utilized digital and analytics tools, leading to inefficiencies in data management and delays in delivering therapeutics to market.

Learn how to obtain highly sensitive, quantitative measurements in real-time without specific tracer gases.

Explore the ways to design and de-risk molecules, streamlining the path to GMP manufacturing and clinical trials, and case studies that provide insight into key activities.